169 related articles for article (PubMed ID: 26124436)
41. Nanotubes connecting B lymphocytes: High impact of differentiation-dependent lipid composition on their growth and mechanics.
Tóth EA; Oszvald Á; Péter M; Balogh G; Osteikoetxea-Molnár A; Bozó T; Szabó-Meleg E; Nyitrai M; Derényi I; Kellermayer M; Yamaji T; Hanada K; Vígh L; Matkó J
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):991-1000. PubMed ID: 28645851
[TBL] [Abstract][Full Text] [Related]
42. Reverse cholesterol transport is regulated by varying fatty acyl chain saturation and sphingomyelin content in reconstituted high-density lipoproteins.
Marmillot P; Patel S; Lakshman MR
Metabolism; 2007 Feb; 56(2):251-9. PubMed ID: 17224341
[TBL] [Abstract][Full Text] [Related]
43. Effects of chemical modification of sphingomyelin ammonium group on formation of liquid-ordered phase.
Goretta SA; Kinoshita M; Mori S; Tsuchikawa H; Matsumori N; Murata M
Bioorg Med Chem; 2012 Jul; 20(13):4012-9. PubMed ID: 22672982
[TBL] [Abstract][Full Text] [Related]
44. Imaging local sphingomyelin-rich domains in the plasma membrane using specific probes and advanced microscopy.
Abe M; Kobayashi T
Biochim Biophys Acta; 2014 May; 1841(5):720-6. PubMed ID: 23860017
[TBL] [Abstract][Full Text] [Related]
45. Annexins as organizers of cholesterol- and sphingomyelin-enriched membrane microdomains in Niemann-Pick type C disease.
Domon M; Nasir MN; Matar G; Pikula S; Besson F; Bandorowicz-Pikula J
Cell Mol Life Sci; 2012 Jun; 69(11):1773-85. PubMed ID: 22159585
[TBL] [Abstract][Full Text] [Related]
46. Content and structure of ceramide and sphingomyelin and sphingomyelinase activity in mouse hepatoma-22.
Rylova SN; Somova OG; Zubova ES; Dudnik LB; Kogtev LS; Kozlov AM; Alesenko AV; Dyatlovitskaya EV
Biochemistry (Mosc); 1999 Apr; 64(4):437-41. PubMed ID: 10231598
[TBL] [Abstract][Full Text] [Related]
47. Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation.
Kovárová M; Tolar P; Arudchandran R; Dráberová L; Rivera J; Dráber P
Mol Cell Biol; 2001 Dec; 21(24):8318-28. PubMed ID: 11713268
[TBL] [Abstract][Full Text] [Related]
48. Induction of an altered lipid phenotype by two cancer promoting treatments in rat liver.
Riedel S; Abel S; Swanevelder S; Gelderblom WC
Food Chem Toxicol; 2015 Apr; 78():96-104. PubMed ID: 25656646
[TBL] [Abstract][Full Text] [Related]
49. Evidence for the role of lipid rafts and sphingomyelin in Ca2+-gating of Transient Receptor Potential channels in trigeminal sensory neurons and peripheral nerve terminals.
Sághy É; Szőke É; Payrits M; Helyes Z; Börzsei R; Erostyák J; Jánosi TZ; Sétáló G; Szolcsányi J
Pharmacol Res; 2015 Oct; 100():101-16. PubMed ID: 26238178
[TBL] [Abstract][Full Text] [Related]
50. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis.
Miyaji M; Jin ZX; Yamaoka S; Amakawa R; Fukuhara S; Sato SB; Kobayashi T; Domae N; Mimori T; Bloom ET; Okazaki T; Umehara H
J Exp Med; 2005 Jul; 202(2):249-59. PubMed ID: 16009715
[TBL] [Abstract][Full Text] [Related]
51. Sphingolipids in mammalian cell signalling.
Ohanian J; Ohanian V
Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
[TBL] [Abstract][Full Text] [Related]
52. Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency.
van Blitterswijk WJ; Klarenbeek JB; van der Luit AH; Alderliesten MC; van Lummel M; Verheij M
Biochem J; 2009 Dec; 425(1):225-34. PubMed ID: 19824885
[TBL] [Abstract][Full Text] [Related]
53. The role of intranuclear lipids.
Albi E; Viola Magni MP
Biol Cell; 2004 Oct; 96(8):657-67. PubMed ID: 15519699
[TBL] [Abstract][Full Text] [Related]
54. Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells.
Sjögren B; Svenningsson P
Acta Physiol (Oxf); 2007 May; 190(1):47-53. PubMed ID: 17428232
[TBL] [Abstract][Full Text] [Related]
55. An adult case of adrenoleukodystrophy with features of olivo-ponto-cerebellar atrophy: II. Lipid biochemical studies.
Taketomi T; Hara A; Kitazawa N; Takada K; Nakamura H
Jpn J Exp Med; 1987 Feb; 57(1):59-70. PubMed ID: 3476777
[TBL] [Abstract][Full Text] [Related]
56. Transbilayer asymmetry and sphingomyelin composition modulate the preferential membrane partitioning of the nicotinic acetylcholine receptor in Lo domains.
Perillo VL; Peñalva DA; Vitale AJ; Barrantes FJ; Antollini SS
Arch Biochem Biophys; 2016 Feb; 591():76-86. PubMed ID: 26702544
[TBL] [Abstract][Full Text] [Related]
57. Sphingomyelins of rat liver: biliary enrichment with molecular species containing 16:0 fatty acids as compared to canalicular-enriched plasma membranes.
Nibbering CP; Carey MC
J Membr Biol; 1999 Jan; 167(2):165-71. PubMed ID: 9916147
[TBL] [Abstract][Full Text] [Related]
58. Photoactivable sphingosine as a tool to study membrane microenvironments in cultured cells.
Aureli M; Prioni S; Mauri L; Loberto N; Casellato R; Ciampa MG; Chigorno V; Prinetti A; Sonnino S
J Lipid Res; 2010 Apr; 51(4):798-808. PubMed ID: 19820263
[TBL] [Abstract][Full Text] [Related]
59. Why high cholesterol levels help hematological malignancies: role of nuclear lipid microdomains.
Codini M; Cataldi S; Lazzarini A; Tasegian A; Ceccarini MR; Floridi A; Lazzarini R; Ambesi-Impiombato FS; Curcio F; Beccari T; Albi E
Lipids Health Dis; 2016 Jan; 15():4. PubMed ID: 26754536
[TBL] [Abstract][Full Text] [Related]
60. Change in contents of biologically active sphingolipids modulating cell growth and survival in hepatoma 27 compared to rat liver.
Kandyba AG; Kobliakov VA; Somova OG; Dyatlovitskaya EV
Biochemistry (Mosc); 2004 May; 69(5):497-500. PubMed ID: 15193122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
